期刊文献+

因心血管不良反应撤市的药物情况分析 被引量:2

Analysis of Withdrawn Drugs Because of Cardiovascular Adverse Reactions
原文传递
导出
摘要 目的:调查近年来因心血管不良反应撤市的药品情况,总结其引发心血管不良反应的特点,为临床合理使用药物提供借鉴。方法:检索国内外文献数据库及互联网,收集近年来因引起心血管不良反应而撤市的药物及其相关信息,并进行总结。结果:近年来在国内外因心血管事件撤市的药品涉及非甾体抗炎药、减肥药、抗组胺药等十余品种。结论:临床应警惕药物的心血管不良反应,规范用药剂量及合并药物,提高临床用药的有效性和安全性。 OBJECTIVE: To investigate the drugs withdrawn from the market because of cardiovascular adverse reactions in recent years, and to sum up the characteristics leading to cardiovascular adverse reactions and provide reference for rational use of drugs in the clinic. METHODS: Retrieved from domestic and foreign literature databases and the Internet, the data of drugs withdrawn from the market because of cardiovascular adverse reactions and related information were collected and summarized in recent years. RESULTS: In recent years because of cardiovascular events, more than ten drugs were withdrawn, involving non-steroidal anti-inflammatory drugs, diet pills, anti-histamine, etc. CONCLUSION: The cardiovascular adverse drug reactions should be noticed. The dosage and combined use of drugs should be standardized, in order to improve the safety and effectiveness of clinical medication
作者 毛璐 高杰
出处 《中国药房》 CAS CSCD 2013年第6期560-564,共5页 China Pharmacy
关键词 心血管不良反应 撤市 分析 Cardiovascular adverse reaction Withdraw Analysis
  • 相关文献

参考文献27

  • 1Bombardier C, Laine L, Reicin A, et al. Comparison of up- per gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis[J].N Engl J Med, 2000, 343(21): 1 520.
  • 2Hagan K. Drug unfit for sale, says judge in compo case [EB/OL]. ( 2010-03-06) [2012-04-08].http://www.theage, com.au/national/drug-unfit-for-sale-says-judge-in-compo- case-20100305-powh.html.
  • 3Lenzer J.Pfizer criticised over delay in admitting drug' s pr- oblems[J]. BMJ, 2004, 329(7 472): 935.
  • 4国家食品药品监督管理局..国家食品药品监督管理局要求停止西布曲明的生产、销售和使用[EB/OL]..http://www.sfda.gov.cn/WSOl/CL0051/55313.html,,(2010-10-30)[2010-11-3]..
  • 5国家食品药品监督管理局.关于停止生产、销售和使用盐酸芬氟拉明原料药和制剂的通知[EB/0L].(2009—01—08)[2012—04—06].btfp://www.sfda.gov.cn/WS01/CL0844/35158.html.
  • 6赵志刚,王爱国.当代药品商品名与别名词典[MI.北京:化学工业出版社,2006:451.
  • 7Anon.Terfenadine to be withdrawn in the US[J]. Reactions Weekly, 1998,683(10) :2.
  • 8刘茂顺,范建荣,訾梅.特非那丁的药物流行病学概况及应用价值评价[J].药物流行病学杂志,1999,8(3):129-132. 被引量:5
  • 9国家食品药品监督管理局信息中心.数据查询[EB/OL].[2012-04-05].http://appl.sfda.gocn/jsp.
  • 10王君,胡霞敏,曾繁典,胡先敏.阿司咪唑上市后心脏毒性安全性评价文献调研[J].药物流行病学杂志,2009,18(2):85-87. 被引量:2

二级参考文献70

共引文献18

同被引文献20

引证文献2

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部